This move benefits Indian patients and has the potential to reshape the global pharmaceutical landscape. With India’s new policy, many multinational biopharmaceutical companies will need to reflect on how India evolves into a priority market.  

Speaking on the decision, Dr. V.G. Somani, Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization, stated, “This policy shift is designed to bring the best of global medical innovation to India more swiftly. By relying on the robust data from international trials, we can ensure that Indian patients benefit from these advancements without unnecessary delays.”

This is more than just a regulatory update for multinational biopharmaceutical companies—it’s a strategic inflection point. India has long been considered a market of interest due to its significant population, favorable policy environment, and emerging middle class. Now, it has signaled its readiness to engage with the global pharmaceutical ecosystem on a new level.

The shift opens up a new market for these pharma companies. It presents an opportunity, but more importantly, a responsibility to extend their voice in India, increasing corporate brand reputation, science communication, and patient advocacy. It’s a turning point that could redefine the global pharmaceutical landscape, underscoring the weight of their role in shaping the future of healthcare.

S. Rajan, Chief Communications, Corporate Affairs and CSR officer at Roche, is among the industry leaders who applauded the GoI news: “This circular is a welcome and much-needed move. The calling out of specific drug categories will help drive a uniform and consistent understanding and avoid any delays. It is important that this is implemented well. We are hopeful that access to the latest innovations will be expedited, addressing unmet healthcare needs and benefitting Indian patients.”

Eliminating the cost barrier of conducting local clinical trials indicates that the GoI is seeking to address a public health need.  One obstacle has been removed, though others remain. Global biopharma companies still face significant challenges operating in India, primarily due to price controls impacting innovative therapies. At this time, India’s government enforces price caps that too often make it financially unviable for multinational companies to launch new, innovative drugs in this market. But it’s not impossible!

This is a favorable move to bring innovative cancer therapies and treatments for rare diseases to people in India. This remains a market of incredible potential, and biopharma companies will need to continue advancing innovative therapies and supporting them with economic solutions to make the best medicines available to more people worldwide. In the meantime, an expansion strategy to India is a medical and communication priority.

Investing in Corporate Brand Reputation

With India becoming a priority market, global pharmaceutical companies must assess how to build relationships with India’s medical and patient advocacy communities.  This is more than relying on marketing muscle. It’s about establishing a reputation as a trusted partner in health innovation and delivery in fast-emerging nations. This could involve initiatives such as collaborating with local healthcare providers, supporting patient education programs, and participating in policy discussions on health innovation and delivery in India.

Even before the GoI decision, the Indian pharmaceutical market was expected to grow to US$130 billion by 2030, up from US$42 billion in 2021, making it one of the fastest-growing health markets in the world.  The decision to embrace other nations’ regulatory moves will likely dramatically accelerate that growth.

Patrizia Cavazzoni, MD, Center for Drug Evaluation and Research, at FDA, has long tracked GoI decisions: “India’s decision to align its drug approval processes with global standards is a significant step that will foster greater collaboration. It also highlights the need for pharmaceutical companies to engage more deeply with Indian stakeholders, ensuring their corporate presence is synonymous with trust and transparency.”

Like audiences everywhere, the Indian public is increasingly discerning the corporate behaviors of those they entrust with their health.  People with urgent health concerns are excited about this decision, which will speed up access to therapies.  Companies must recognize that investing in world-class science may not be enough in the post-COVID era to secure physician support and consumer confidence.  To facilitate market entry in India requires establishing corporate identities people can trust.

The Imperative for Science-Based Communication

Effective science communication will be paramount as these companies introduce their health innovations into India. The complexities of advanced medical treatments, particularly newly approved ones, require careful explanation to health providers and the public.

Transparent, accessible communication will help demystify these innovations, fostering greater acceptance and understanding.  This also calls on major hospital provider systems that served as drug trial sites for these regulatory-approved medicines to step forward and share clinical backgrounds and best practices in patient care.

According to published studies, 87% of Indian physicians are highly engaged in continuing medical education (CMEs) and are keen to stay updated with the latest advancements in treatments and drug safety protocols, highlighting a receptive audience for apparent, data-driven communication efforts. Companies have an opportunity to lead by example, demonstrating that they are bringing innovative products to market by showing commitment to educating and empowering Indian patients and health professionals.

Dr. V.G. Somani, DCGI, emphasized the importance of clear communication in this new regulatory landscape: “Pharmaceutical companies must now rise to the challenge of effectively communicating the science behind these treatments to healthcare providers and patients. This will be crucial in ensuring that the benefits of these new therapies are fully realized.”

Patient Advocacy as a Pillar of Reputation

Most crucially, multinational pharmaceutical companies must prioritize patient advocacy in India. The recent regulatory change will undoubtedly bring some innovative treatments to the market. The policy change is a catalyst toward ensuring treatments are accessible, affordable, and aligned with patients’ needs.  However, it remains a complex challenge.  India has 1.4 billion people – as many as 400 million classified as middle class – and a diverse and complex healthcare insurance system that includes government, private, and, in some cases, a heavy reliance on consumer out-of-pocket payments.

Companies must engage with patient communities, understand their unique challenges, and advocate for solutions that address them. Organizations such as the Organization for Rare Diseases India (ORDI) and the Lysosomal Storage Disorders Support Society (LSDSS) are among the advocacy groups advocating for patients with rare diseases in India. ORDI ensures early diagnosis, treatment, and support for individuals with rare diseases, while LSDSS focuses on increasing awareness and providing access to therapies for lysosomal storage disorders.

Dr. Manjit Singh, LSDSS Executive Committee President, commented on the significance of this regulatory change: “This policy decision is a critical step forward for patients with rare diseases in India. It will help bring much-needed therapies to the market faster. Still, it also places the onus on pharmaceutical companies to ensure these treatments are accessible and affordable for all patients.”

By engaging with these patient advocacy groups, pharmaceutical companies can help amplify patients’ voices, ensuring their needs are central in developing and distributing new treatments. Over time, this will include ensuring peer-reviewed science is shared with India-based media covering health and science, prioritizing pricing strategies to ensure accessibility to patient support programs, and investing in awareness efforts so that people with these conditions understand the importance of medication adherence.

The Government of India’s decision to waive local clinical trial requirements for drugs approved by gold-standard regulatory bodies is forward-thinking and aligns with the country’s demonstrated efforts to improve health delivery for serious illnesses. Multinational biopharmaceutical companies should get the signal that India is a welcoming market ready to be at the forefront of their phyician education and patient advocacy efforts. By investing in corporate brand awareness, scientific communication, and patient advocacy, these companies can contribute meaningfully to the health and well-being of India and other emerging nations. 

One barrier to access has been lowered for innovative cancer and rare disease therapies.  In reality, others remain.  One of the biggest is that the Indian National Pharmaceutical Pricing Authority sets ceiling prices – caps – that include certain patented and innovative drugs. The pricing formula often uses a cost-plus approach, a non-starter for significant biopharma companies championing breakthrough therapies in a price-referring policy environment.  But the door to possibilities has opened wider.

In responding to the GoI welcoming decision with action, the biopharmaceutical industry can reinforce its commitment to good business, science, and patient care—a true win-win-win for all involved and a global health impact. The message is clear: Pharma companies consider the possibilities and  “Go to India!”

The post India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need appeared first on Medika Life.

This year is no exception. Thought leaders, innovators, philanthropists, and community activists from around the globe, united in their quest for solutions, will meet in Chicago on June 4-5^th. An impressive roster of C-Suite and policy leaders are delivering keynotes and moderate roundtables, including Dr. Chelsea Clinton, vice-chair of the Clinton Foundation, and Governor JB Pritzker of Illinois, both well-known for their longstanding commitment to social impact efforts.

Landmark Ventures follows a unique model combining business development services, investment banking, and special events, also hosts the CIO Summit, which convenes business, technology, venture capital, and innovation leaders. These two gatherings enable Landmark to bring diverse voices together to advance needed change.

Spirit of Collaboration

The Summit’s true power lies in assembling participants from diverse sectors, each bringing their perspectives and expertise. Entrepreneurs with groundbreaking ideas, non-profit leaders with deep community insights, corporate executives bringing resources and economic clout to the table, and policymakers able to effect change converge, contributing to a tapestry of perspectives and complementary skills. The resultant cross-pollination of ideas leads to innovative solutions that would likely not emerge in more homogenous settings.

Beyond buzzwords, inclusivity and diversity are the essence of the Summit’s ethos. The complex, multifaceted problems our world faces require input from a broad range of stakeholders, and those who attend believe that every voice, regardless of its size, matters and contributes to the collective impact the gathering seeks. 

Fostering Innovation and Driving Impact

Innovative ideas that lead to action are the lifeblood of the Social Innovation Summit. The event serves as an incubator, providing a platform to present ideas in motion and receive feedback from a policy- and business-savvy audience. This supportive environment can help refine concepts into viable, effective solutions.

The Innovation Showcase, a Summit highlight, offers startups and social enterprises an opportunity to pitch their projects to a receptive panel of judges and an audience of interested investors and potential partners. The showcase provides high-level exposure, valuable feedback, and a chance to secure funding essential for scaling solutions.

Social Innovation Summit impacts reverberate well beyond the event itself. Discussions and connections often lead to collaborative projects that effect change, from local community initiatives to global movements. This is the Summit’s greatest strength. Collaborations that took root at the Summit have led to education, healthcare, and environmental sustainability initiatives, benefiting underserved communities worldwide.

According to Barb Short, senior director, Corporate Social Responsibility at Sanofi, who is attending her third Summit and speaking at a Day One Roundtable titled HEALTH EQUITY & ACCESS: “The Social Innovation Summit has always been my go-to to learn from changemakers who are not only bold, but also are sleeves-rolled, connecting across sectors to understand nuance and innovate new collaborative methods toward meaningful movement.”

Models for Success and Agents of Change

The Summit also spotlights successful social innovation models, providing practical examples for others to follow. These case studies demonstrate how meaningful change is achieved, providing a roadmap for replicating or adapting successful strategies in other communities.

A notable success story: a not-for-profit social enterprise that developed a low-cost water purification system for use in developing countries attracted investors and partners during the Summit, leading to partnerships that drove broad adoption of its technology. Today, millions have access to clean drinking water thanks to conversations and connections made during the two-day meeting.

Empowerment is also a key theme at the Summit. Participants gain the skills and confidence to drive community change through workshops, mentoring sessions, and networking opportunities. This is vital for young leaders and emerging social entrepreneurs, who often face significant barriers to achieving their goals.

The Leadership Lab, one of the Summit’s standout sessions, provides intensive training and mentorship to these emerging leaders. Participants learn about project management and social impact strategies, which equip them with the tools to lead successful initiatives. Many alum have gone on to create successful projects in their communities, underscoring the Summit’s lasting influence.

Systemic Challenges

While celebrating individual innovations, the Summit recognizes the need to tackle systemic challenges, such as poverty, inequality, and climate change. It provides a forum for discussing these broader issues and developing strategies for effectively tackling them.

The Summit facilitates dialogue between different sectors that must be involved in addressing systemic change. For example, a panel might bring together policymakers, business leaders, and activists to discuss strategies for reducing income inequality. By fostering these cross-sector dialogues, the summit helps build the coalitions needed to address challenges of the greatest possible scope.

Is it a Meeting or a Movement?

Finally, the Social Innovation Summit serves as a powerful platform for advocacy. The summit shapes public discourse and influences policy by spotlighting critical social issues, exploring innovative, collaborative solutions, and—critically—building the foundation for empowered advocacy. Many speakers use their platform to serve as agents for change, raising awareness and mobilizing support for worthy causes addressing the most important issues of our time.

For example, a recent Summit speaker used their platform to call for criminal justice reform, highlighting the need for systemic changes to more comprehensively address the challenges of mass incarceration. This speech raised awareness and inspired participants to advocate for change, demonstrating the Summit’s ripple effect.

The Social Innovation Summit in Chicago is more than an event; it’s a movement driving societal change. By uniting diverse participants, fostering innovation, and addressing systemic challenges, the Summit’s impacts reverberate. Its emphasis on inclusivity, collaboration, and empowerment ensures that a wide range of voices are heard and that innovative solutions receive the support they need to succeed.

As the Summit continues to grow and evolve, its influence will only increase, inspiring more individuals and organizations to join the movement to work toward social good. In a world that faces complex, interconnected challenges, the Social Innovation Summit stands as a testament to the power of collaboration and innovation in creating a better future for all.

Attending the Summit with a story to share on how this gathering has influenced your purpose and social impact efforts – reach out!

[Special thanks to John Bianchi for his review of this preview piece and to the Landmark Ventures team for inviting Medika Life to attend this inspiring gathering of changemakers.]

The post The Social Innovation Summit: Catalyzing Societal Change appeared first on Medika Life.

Medika Life will be on-hand and covering this gathering – meeting with attendees and sharing highlights from the conversations. Hear from Amir why this gathering – with more than 100 speakers – should be on your calendar of 2024 meetings to attend.

The post Digital Health AI and Innovation Summit to Gather in Boston this Fall appeared first on Medika Life.

Date of Release: December 14, 2021

NEW YORK — Global independent marketing and communications firm FINN Partners today announced that starting January 1, 2022, Medika.Life – a global opinion and news platform recognized for hosting and distributing health-sector thought-leaders’ content to its 100,000 and more monthly readers, joins FINN as a unique operating unit. Medika.Life and its regular content, which includes the popular listicles “Fifty of the Most Influential Voices in Healthcare,” “Fifty of the Most Impactful Tech Innovators in Digital Healthcare” and “The 50 Most Influential Leaders in Pharmacy,” will be championed by Gil Bashe, Global Health Chair, FINN Partners, and Noah Finn, Managing Partner, Integrated Marketing.

Editors-in-Chief Robert Turner and Jeffrey Livingston, MD will assume new roles as Founding Editors-in-Chief Emeritus. Bashe will take on an additional agency role as Medika.Life editor-in-chief. Bashe and  Noah Finn will serve together as co-publishers to support operations of the platform, which now hosts more than 40 authors sharing content in general medicine, health policy, ecohealth, disease awareness and issues of interest for patients, payers and providers. Popular contributors, including physician leader Hesham A. Hassaballa, MD, a  New York Times featured Pulmonary and Critical Care Medicine specialist in clinical practice for more than 20 years, and Lisa Bradburn, a psychotherapist writing about the nexus between technology and the human condition, will continue in their roles. Technology theorist John Nosta, contributor to Bloomberg, Forbes, Fortune and Psychology Today will be joining the platform and additional editors and authors will be added in the months ahead.

“Vision and values drive mission, and the Medika.Life platform – through its content and reach – seeks to tackle many of the same societal challenges that FINN, as a major global communications agency, is working to address with our clients,” said Peter Finn, Founding Partner, FINN Partners. “When Medika.Life sought out a committed partner that mirrored its values and vision to support its mission and continued growth, we were honored to be approached,” he added.

“Medika is far more than simply aggregating medical data and information. Since our founding in 2020, our goal has been to advocate for a medical community committed to uniting the fragmented health ecosystem toward a globally accessible, ethical, and equitable industry that places the needs of patients at the forefront,” shares Robert Turner, co-founder and Co-Editor-in-Chief Emeritus, Medika.Life.  “We invited Gil Bashe to write for our platform at its genesis. In him, we found a kindred spirit equally dedicated to our efforts. It made the conversation with FINN a given as we all looked to support the platform’s future,” he added.

“We amplify the voices of medical professionals who seek positive reform within the industry, and we provide a platform to highlight injustice, inequality, and racial bias in medicine,” reflects Jeffrey Livingston, MD, co-founder, and Co-Editor-in-Chief Emeritus, Medika.Life, who is a board-certified ob/gyn and CEO, MacArthur Medical Center, in Dallas, TX. “We created Medika.Life recognizing that even the most inspired and motivated voices require a network of committed fellow professionals for support and collaboration,” he added. Livingston is also editor-in-chief of Being Well on Medium, which will continue its collaboration with Medika.Life by sharing content across platforms.

“Physicians, patients, policy leaders, planetary health advocates, and health innovation leaders saw an urgent need to reach like-minded people to foster conversation and motivate change. Medika.Life quickly became a go-to for sharing bold ideas. With its continued cross-platform connection to Being Well on Medium, Medika – with added support from FINN – will provide authors expansive reach to address public health priorities and share ideas directly with key audiences,” said Gil Bashe, Chair Global Health, FINN.

Together with the Pharmacy Podcast Network (PPN) – a news organization absorbed by FINN in November that is known for hosting and distributing content to an audience of 100,000+in the pharmacy community – Medika.Life will form the core of the FINN new omni-channel communications effort, which offers invited contributors opportunities to share their ideas and opinions with influential and important audiences throughout the health ecosystem.

About FINN Partners, Inc.

Founded in 2011 on the core principles of innovation and collaborative partnership, FINN Partners has more than quadrupled in size over the past 10 years, becoming one of the fastest-growing independent, integrated marketing agencies in the world. The full-service marketing and communications company’s record-setting pace is a result of organic growth and integrating new companies and new people into the FINN world through a common philosophy. With more than 1,000 professionals, FINN provides clients with global access and capabilities in the Americas, Europe, and Asia. In addition, FINN provides its clients with access to top tier agencies around the world through its membership in the global network PROI. Headquartered in New York, FINN’s other offices are in Atlanta, Boston, Chicago, Denver, Detroit, Dublin, Fort Lauderdale, Frankfurt, Hong Kong, Honolulu, Jerusalem, London, Los Angeles, Munich, Nashville, Paris, Portland, San Francisco, Seattle, Shanghai, Singapore, Southern California, and Washington D.C.

Find us at finnpartners.com and follow us on Twitter and Instagram at @finnpartners.

Find Medika.life at medika.life and on Twitter at @medikalife

MEDIA CONTACTS:

Gil Bashe

gil.bashe@finnpartners.com | gil.bashe@medika.life | CELL: 732 371 0922

Celia Jones

celia.jones@finnpartners.com | CELL: 773 885 9781

The post FINN Adds Medika Life to its Omni-Channel Communications Platform appeared first on Medika Life.

Forget election results and petty political divisions. The time has come to focus on our humanity and to heed the call to arms. We are all one family under the shared flag of our humanity and we have forgotten this or chosen to ignore it. If you want to help to end the pandemic and return our lives to normality, we ALL need to take action.

We’ve stumbled and fumbled our way through a difficult year and the calendars we use to mark our progression on this beautiful rock we call home have called time. 

It’s time for the yearly do-over. Fresh goals and aspirations and with it, new hope. Hope, that science and the magical engineers that unlock the secrets of hidden worlds, have afforded us. 

Covid was never going to wipe out the human race. It just wasn’t deadly enough, but it’s wrought destruction on families across the globe and tested the resolve and resources of our medical frontline workers. It’s also far from done and Americans, more than any other country, are realizing this painful truth. 

2020 has been a trial by fire. A global wake up call of our fragility and our inability to properly protect our communities and those we love. 

Covid has also highlighted the importance of science and who mankind’s real enemies are. It is not weapons of mass destruction and each other we need to be wary of, but rather invisible agents, carried on the wind. Viral particles, too small for the human eye to perceive, but potentially deadly in their intent. 

It is these viral agents that represent the real threat to humanity and against which conventional weapons of war are powerless. The coronavirus has provided the call to arms and we will ignore it at our own peril. 

We have an opportunity now, as we face the rest of this decade, to come together cohesively, for the first time in our collective history. 

To join forces in creating a new army, focused on defeating this unseen enemy. A global force that eschews traditional weapons and elects instead to turn to science for its tools. It is in science that our salvation lies. Our salvation and the generations to follow, our children, and theirs. 

We’ve started to gain a better understanding of the real nature of this new enemy and as vaccines make their way into our communities, we are afforded hope of a return to normality. 

The eventual resumption of whatever our lives will look like post-pandemic is inevitable. What matters now is how we mark this passage of time. Science can only provide us with weapons. Victory with minimal loss of life is our goal and that’s up to the footsoldiers. To you and I, citizens of the world. Science can only do so much, then the responsibility falls to you and I to act. 

Forget election results and petty political divisions. The time has come to focus on our humanity and to heed the call to arms. We are all one family under the shared flag of our humanity and we have forgotten this or chosen to ignore it. If you want to help to end the pandemic and return our lives to normality, we ALL need to take action. 

Vaccination is a critical part of this process. The longer it takes, the more lives we lose, the longer our businesses remain shuttered and our lives kept on hold. 

You are by no means powerless. You have the internet at your disposal and you can bring huge pressure to bear on failing government institutions that don’t ensure rapid delivery of vaccines, governors who don’t provide an adequate distribution network within your communities, and unreliable public resources that fail to assist in deploying vaccines. 

Speak up now. Particularly if you are in at-risk groups. Your lives could depend on the vaccine and soldiers cannot be expected to fight the good fight if they aren’t supplied with weapons. If your government and governors are leaving you defenseless, hold them accountable on social media, and please do, when you find systems that work efficiently, sing their praises. 

Everyone wants to know they are appreciated. Let them know. Use Social Media and if possible, send personal messages of thanks. Honest praise can be much-needed sustenance for the soul in hard times and your words can make all the difference.

Medika will engage with all of you to assist in this process in whichever way we can. If you want to share useful vaccination resources and projects from within your states that are effective, send them to us and we’ll publish them. If something is failing, tell us we will help to highlight it and find solutions. You can find contact us through the website, on social media, or simply email us at vaccinateus@medika.life

Let’s start 2021 by all really starting to look out for each other. Every human life we save matters. It starts with each one of us, wear a mask in public, set an example. It says ‘I care about you’ and it shows your humanity. It’s that simple. 

This year, and how we move forward, really is in our hands. Let’s do it together and allow science the space it needs to hone our weapons. 

Finally a word of thanks from all of us to our front-liners who have worked tirelessly and selflessly to keep our loved ones alive. You’re our first line of defense and you haven’t wavered. We are immensely proud of you and deeply grateful. 

Our deepest sympathies go out to those who’ve lost people they love. To all those of you who enter the new year without the companionship of loved ones you’ve lost to Covid, or for that matter, any disease, let’s honor their memories by committing to the fight. At the very least, it will help spare others the anguish you have had to endure. 

The fight is far from over, but we have a light now and between all of us, we can ensure it glows brightly. We wish you happiness and health for the coming year. 

Jan 01, 2021

Robert Turner, EIC and Founder of Medika Life

Dr Jeff Livingston, Founder of Medika Life and EIC, BeingWell

The post A New Year’s Message of Hope from Medika Life appeared first on Medika Life.

Her actions have led to changes in the law in the United Kingdom, quacks being struck off their medical boards, and various charlatans, health guru’s and pseudo-scientific con artists being de-platformed on Facebook, Twitter, and other social media platforms.

We look forward to being able to amplify her voice even further as we engage in a proactive campaign that seeks changes to legislation in the USA to further protect the public from medical misinformation and empowers government bodies (FDA, DOJ) to act aggressively and with authority against these purveyors of death. Social media is firmly in our sights as their timid and unresponsive attitude to a growing threat to our health is unacceptable. Facebook, in particular, enables quackery, dangerous and illegal treatments and by association, endorses child abuse by users on its platform.

You can read Fiona’s blog by following this link and do make a point of following and supporting her on social media via her Twitter account. Be warned that she doesn’t pull any punches and much of the content she posts relating to the health abuse of autistic children is both graphic and upsetting. If you are a sensitive reader, do proceed with caution.

You can learn more about Medika’s Quack Scale and Rotten Retailers list by following the respective links.

The post Medika Welcomes Fiona O’Leary to Our Editorial Team appeared first on Medika Life.

Press and PR

For information on company structure, founders, and partners or to request interviews or appearances please direct your email to pr@medika.life

Reproducing material for commercial/derivative

To reproduce material found on the Medika Life website that is not covered by our Attribution-NonCommercial-NoDerivs CC BY-NC-ND license please contact our editorial department at editorial@medika.life

Joint Ventures/Partnerships

We love expanding our network and we are always receptive to new ideas and partnerships. To get your request in front of the right eyes, direct your email to partners@medika.life

Press Kit

To request a press kit for Medika Life or MOBILIZE™ Health please send us an email to press@medika.life. Alternatively, you can find out more about Medika here and here and you can download our marks and brand logos here

Our registered address in the USA is shown below.

1212 Corporate Drive,
Suite 100,
Irving,
Texas,
75039

The post Press and Media Enquiries appeared first on Medika Life.

If the project you are engaged in requires alternate or additional artwork, please reach out to us. Please refer to the conditions of use in the footer.

The Medika M

Details

File Name: Medika Life Brand Logo
Dimensions: 512 x 512
File Type: PNG
Colors: #FFFFFF, #1976B2
Download Link: Download

The Medika Life Logo

Details

File Name: Medika Life Full Logo White Back
Dimensions: 544 x 180
File Type: PNG
Colors: #FFFFFF, #1976B2, #000000
Download Link: Download

The MOBILIZE™ Health Logo

Details

File Name: MOBILIZE™ Health Logo White Back
Dimensions: 544 x 180
File Type: PNG
Colors: #000000, #1976B2, #666666
Download Link: Download

The reach+ Logo

Details

File Name: reach+ Advertising Logo
Dimensions: 600 x 400
File Type: PNG
Colors: #000000, #31AAE2, #666666, #FFFFFF
Download Link: Download

Conditions of Use

Please respect the proportions, scale, and colors shown above when using the logos or marks. All website links attached to the images should direct to https://medika.life. The use of the marks shall not indicate a business association or partnership with Medika Life or our associated businesses and partners unless prior consent has been obtained from Medika.

For assistance, questions and enquiries relating to the above or to request additional materials, please email brand@medika.life

The post Medika Life Logo’s and Branding appeared first on Medika Life.

The quality, relevance and reliability of the content we feature is to a large degree determined by our editors and that’s one of the reasons we are so pleased to welcome Dr Hesham A Hassaballa and Dr Patricia Farrell to Medika in an editorial capacity.

You can read more about each of them on the links below and do peruse their articles. They are also contributors to Medika and their writing offers important and insightful views on their individual fields of expertise.

Do follow them on their social networks and feel free to connect or comment on the articles. If you need advice with regards materials or drafts you’d like to submit to Medika for their particular fields of expertise, you can contact them directly from your profile page.

Dr Hesham A Hassaballa

Editor: Cardio and Pulmonary

Hesham writes on a broad range of topics and you can read his articles and interview on his Medika column here. You can view Hesham’s full profile here. He is also an editor on Medika’s Medium publication, BeingWell and you can find his writing on Medium here

Dr Patricia Farrell

Editor: Mental Health

Patricia is a prolific author and you find our more about her and read both her interview and articles from her Medika column. You can view Patricia’s full profile here and read her writing on Medium here.

For more information on the Medika Editorial team, you can refer to this page.

The post Medika Life Welcomes Two New Editors to the Team appeared first on Medika Life.

We do this by amplifying their voices, drawing attention to their businesses, campaigns, crusades, and, occasionally, their plights. We focus on two essential determinant – people and planet. Patient outcomes and planetary sustainability. This is what drives ethical public health and the individuals who place the importance of people’s health at the forefront of their endeavors can count on us for support.

This forward-looking, patient-centered approach fuels much of the new medical and technical innovation occurring right now in healthcare across the globe. Applying the power of social media and the internet to networked groups of individuals across various sectors of healthcare is changing the face of medicine. We are proud to be involved in a pivotal moment in health evolution and privileged to be able to showcase what we consider to be, the best side of humanity.

Motivated individuals, functioning cohesively with one singular goal. The provision of accessible and equitable healthcare as a fundamental global right and an environment that contributes to our well-being. It is ambitious and overdue and we have no doubt that the voices echoing now through health have the focus, desire, and innovative mindsets to deliver. Change is coming, shout it from the hilltops. We do.

MOBILIZE™ Health

MOBILIZE™ Health is the non-profit component of Medika Life. It addresses topical and pressing health-related issues within the industry and considers the social effects on the societies it impacts as a key determinant in the projects it creates. On occasion, we will step outside of these bounds to deliver help to communities, simply for the fact that we can. You can see an example of a recent aid project in the Philippines here.

We believe in the importance of small positive community-driven actions and how these can filter down to the affected societies. Everyone’s voice matters and where we can, we strive to improve our world, for the sake of the patients we serve and for a better future.

Our Founders

Medika Life was founded in early 2020 by two friends, Jeff Livingston, MD, and Robert Turner. They share many of the same values and are driven to providing clear, informative, ethical and accurate medical and health-related information to the public. A part of this is countering fake news and misinformation, and Medika Life dedicates resources to outing quacks and health charlatans that pose a risk to public health.

This digital publication is dedicated to an eclectic mix of general health and disease information, ecohealth and environmental priorities, industry news and opinion, influencers and industry-related press releases. The majority of the scientific articles are prepared by qualified medical professionals, most experts in their chosen fields. Whether you’re interested in or affected by health, Medika offers something for everyone, patient and professional alike, industry and government leaders, advocates and innovators and provides a forum for open transparent debate on key issues affecting health and environment.

Jeff lives and works out Irving, Texas in the US as an OBGYN and is CEO of the medical group, Macarthur Medical Center. Jeff is EIC of BeingWell, Medika’s Medium publication. You can connect with him on LinkedIn and Twitter or via email at jefflivingmd@medika.life.

Robert lives between London and the Philippines. He is the Medika Life founding editor, a published author with deep routes in the medical community and founder of Cre8tive Digital Media. You can connect with him on LinkedIn and Twitter or via email at robertturner@mediaka.life.

Jeff and Robert were joined by Gil Bashe in 2020, who started as an author on the platform, evolved into our editor for ecohealth and environment, and then stepped in as editor-in-chief. Together with Jeff and Robert, he has worked to advance the efforts of this leading digital publication to invite diverse ideas that can lead to improving the human condition.

The post About Medika Life appeared first on Medika Life.